Go Pro
→ ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$7.08
-13.3%		$6.66
$1.32
▼
$9.69
$1.81B2.098.02 million shs10.88 million shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.04
-1.6%		$18.60
$14.75
▼
$30.02
$1.77B1.021.79 million shs1.59 million shs
NovoCure Limited stock logo
NVCR
NovoCure
$14.84
-2.6%		$16.45
$9.82
▼
$21.45
$1.73B0.961.87 million shs1.23 million shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
▼
$19.01
$535.71M2.17444,551 shsN/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
0.00%+9.27%-7.87%+31.31%+291.38%
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.00%+10.64%+11.54%-6.37%-9.82%
NovoCure Limited stock logo
NVCR
NovoCure
0.00%-15.92%-13.72%-10.71%+35.28%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+0.58%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$7.08
-13.3%		$6.66
$1.32
▼
$9.69
$1.81B2.098.02 million shs10.88 million shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.04
-1.6%		$18.60
$14.75
▼
$30.02
$1.77B1.021.79 million shs1.59 million shs
NovoCure Limited stock logo
NVCR
NovoCure
$14.84
-2.6%		$16.45
$9.82
▼
$21.45
$1.73B0.961.87 million shs1.23 million shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
▼
$19.01
$535.71M2.17444,551 shsN/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
0.00%+9.27%-7.87%+31.31%+291.38%
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.00%+10.64%+11.54%-6.37%-9.82%
NovoCure Limited stock logo
NVCR
NovoCure
0.00%-15.92%-13.72%-10.71%+35.28%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+0.58%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.40
Hold$5.56-21.48% Downside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.55
Moderate Buy$30.0836.49% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.14
Hold$21.2042.86% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ZIMV, BFLY, NVCR, and EYE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/24/2026
NovoCure Limited stock logo
NVCR
NovoCure
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$32.00
7/24/2026
NovoCure Limited stock logo
NVCR
NovoCure
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/24/2026
NovoCure Limited stock logo
NVCR
NovoCure
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$18.00 ➝ $20.00
7/23/2026
NovoCure Limited stock logo
NVCR
NovoCure
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$46.00 ➝ $52.00
7/14/2026
NovoCure Limited stock logo
NVCR
NovoCure
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/13/2026
NovoCure Limited stock logo
NVCR
NovoCure
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$17.00
6/18/2026
NovoCure Limited stock logo
NVCR
NovoCure
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$48.00 ➝ $46.00
6/1/2026
NovoCure Limited stock logo
NVCR
NovoCure
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
5/15/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$40.00 ➝ $39.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$25.00
(Data available from 8/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$97.61M18.48N/AN/A$0.77 per share9.20
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.99B0.89$1.79 per share12.31$10.96 per share2.01
NovoCure Limited stock logo
NVCR
NovoCure
$655.35M2.64N/AN/A$3.04 per share4.88
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.86 per share10.22$13.83 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$77.06M-$0.30N/AN/AN/A-66.74%-33.99%-22.96%N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
$29.60M$0.5738.6727.901.922.31%6.41%2.81%8/12/2026 (Confirmed)
NovoCure Limited stock logo
NVCR
NovoCure
-$136.23M-$1.30N/AN/AN/A-21.25%-44.00%-15.85%N/A
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/AN/A-4.39%6.37%3.34%N/A

Latest ZIMV, BFLY, NVCR, and EYE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.1835N/AN/AN/A$499.74 millionN/A
7/30/2026Q2 2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.0350-$0.01+$0.0250-$0.05$29.16 million$32.61 million
7/23/2026Q2 2026
NovoCure Limited stock logo
NVCR
NovoCure
-$0.3315-$0.13+$0.2015-$0.13$172.44 million$183.58 million
5/13/2026Q1 2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.43$0.45+$0.02$0.38$545.09 million$543.88 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
4.06
3.06
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.25
0.62
0.37
NovoCure Limited stock logo
NVCR
NovoCure
0.58
2.89
2.70
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
21.99%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.40%
NovoCure Limited stock logo
NVCR
NovoCure
6.55%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
460254.63 million198.64 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,13880.12 million78.19 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,605116.45 million108.82 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.21 million26.69 millionNo Data

Recent News About These Companies

ZimVie Stock Guidance | NASDAQ:ZIMV | Benzinga
July 10, 2026  |  benzinga.comhttps://www.benzinga.com/quote/ZIMV/guidance
ZimVie Announces the Launch of Azure(TM) Multi-Platform Product Solutions
July 3, 2026  |  stockhouse.comhttps://stockhouse.com/news/press-releases/2023/10/17/zimvie-announces-the-launch-of-azure-tm-xa0-multi-platform-product-solutions
ZimVie Inc.
April 8, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/zimv/research-ratings?countrycode=mx
Inogen adds med tech vet to board
April 7, 2026  |  hmenews.comH
Highridge Medical begins limited rollout of activL lumbar disc
February 27, 2026  |  massdevice.comhttps://www.massdevice.com/highridge-medical-limited-rollout-activl/
Double-digit valuations attract PE to dental care: 5 deals
January 30, 2026  |  pehub.comhttps://www.pehub.com/double-digit-valuations-attract-pe-to-dental-care-5-deals/
After years in the shadow of Big Tech, Ariel's value fund bounces back
November 14, 2025  |  chicagobusiness.comC
ZimVie Board Backs Year-End Transaction
October 27, 2025  |  msn.comhttps://www.msn.com/en-us/money/economy/zimvie-board-backs-year-end-transaction/ar-AA1PhtfW
ZimVie Inc Completes Acquisition by ARCHIMED
October 20, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/zimvie-inc-completes-acquisition-by-archimed?utm_source=marketbeat.com&utm_medium=referral
ArchiMed MedTech takes dental tech company ZimVie private for $730m
October 20, 2025  |  pehub.comhttps://www.pehub.com/archimed-medtech-takes-dental-tech-company-zimvie-private-for-730m/
ARCHIMED Completes Acquisition of ZimVie Inc. in Strategic Move to Enhance Dental Implant Solutions
October 20, 2025  |  quiverquant.comQ
ZimVie Announces Completion of its Acquisition by ARCHIMED
October 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/20/3169457/0/en/zimvie-announces-completion-of-its-acquisition-by-archimed.html
Inside 4 orthopedic medtech splinters
October 15, 2025  |  beckersspine.comB
ZimVie Shareholders Approve Acquisition, Set for October Delisting
October 12, 2025  |  aktiencheck.deA
ZimVie Inc Stockholders Approve Acquisition by ARCHIMED
October 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/zimvie-inc-stockholders-approve-acquisition-by-archimed?utm_source=marketbeat.com&utm_medium=referral
ZimVie Inc.: ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
October 10, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-10/66668515-zimvie-inc-zimvie-stockholders-vote-to-approve-acquisition-by-archimed-399.htm
ZimVie shareholders approve acquisitiion by ARCHIMED
October 10, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/zimvie-shareholders-approve-acquisitiion-by-archimed/ar-AA1OetFl
ZimVie Stockholders Approve Merger with ARCHIMED Affiliate, Closing Expected on October 20, 2025
October 10, 2025  |  quiverquant.comQ
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
October 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/10/3164889/0/en/zimvie-stockholders-vote-to-approve-acquisition-by-archimed.html
ZimVie Inc Faces Legal Challenges Over Merger
October 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/zimvie-inc-faces-legal-challenges-over-merger?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A semiconductor wafer with the SK hynix logo displayed inside a manufacturing fabrication facility.
SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
By Thomas Hughes | July 7, 2026
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
A digital illustration of a glowing AI brain connected to circuit pathways against a city skyline backdrop.
2 AI Stocks That Could Benefit as AI Moves Beyond the Data Center
By Thomas Hughes | July 5, 2026
Popular Inc. logo displayed on the exterior wall of a modern corporate building at sunset.
Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
By Peter Frank | August 1, 2026
Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$7.08 -1.09 (-13.29%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$7.10 +0.01 (+0.20%)
As of 07/31/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

National Vision stock logo

National Vision NASDAQ:EYE

$22.04 -0.36 (-1.61%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$22.04 0.00 (-0.02%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$14.84 -0.39 (-2.56%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$14.91 +0.07 (+0.47%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas